Literature DB >> 24365404

Subjects at Ultra High Risk for psychosis have 'heterogeneous' intellectual functioning profile: a multiple-case study.

Emilie Magaud1, Yannick Morvan2, Alice Rampazzo3, Charlotte Alexandre3, Dominique Willard3, Raphaël Gaillard3, Mathilde Kazes4, Marie-Odile Krebs3.   

Abstract

In Ultra High Risk (UHR) studies, intellectual functioning is commonly assessed using premorbid IQ tools as a covariate. The aim of this study was to show that the use of the Wechsler Adult Intelligence Scale (WAIS) could yield accurate neuropsychological profiling and that an alternative approach such as a multiple-case study could be a more interesting way to isolate discrete cognitive processes in the early stage of illness. The studied population consisted of 198 adolescents and young adults (16-30 y.o.) referred to our outpatient clinic. After the CAARMS' interview, we defined 3 subgroups: UHR (N=104), First Episode (FE; N=30), and Help-Seekers (HS; N=64) who were neither UHR nor psychotic. Intellectual functioning was assessed by the WAIS-III (9 subtests version) and 'heterogeneous' intellectual profiles were defined based on the existence of a 3-point difference in scoring at subtests constitutive of the same WAIS index. While UHR did not differ from FE or HS on WAIS' scores and sub-scores, the multiple-case study indicated a higher proportion of 'heterogeneous' profiles in the Verbal Comprehension Index in the UHR sample than in FE and HS (p=0.04). The disease progression could heterogeneously impact on specific domains, in patterns depending on the stage of the illness. This approach exploring intra-subject WAIS performances might be more relevant than the use of global scores in detecting the subtle cognitive alteration of emerging psychosis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adolescents; Early detection; High functioning; Intelligence; Neuropsychological; Schizophrenia

Mesh:

Year:  2013        PMID: 24365404     DOI: 10.1016/j.schres.2013.11.002

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  3 in total

1.  Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Authors:  Ariel Schvarcz; Carrie E Bearden
Journal:  Curr Behav Neurosci Rep       Date:  2015-01-18

2.  Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.

Authors:  Zachary B Millman; Caroline Roemer; Teresa Vargas; Jason Schiffman; Vijay A Mittal; James M Gold
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

3.  Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Authors:  M K Chan; M-O Krebs; D Cox; P C Guest; R H Yolken; H Rahmoune; M Rothermundt; J Steiner; F M Leweke; N J M van Beveren; D W Niebuhr; N S Weber; D N Cowan; P Suarez-Pinilla; B Crespo-Facorro; C Mam-Lam-Fook; J Bourgin; R J Wenstrup; R R Kaldate; J D Cooper; S Bahn
Journal:  Transl Psychiatry       Date:  2015-07-14       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.